ARTICLE-6: General obligation to register substances on their own or in preparations [
go to this ARTICLE]
ARTICLE-17: Registration of on-site isolated intermediates [
go to this ARTICLE]
... (b) the
identity of the
intermediate as specified in sections 2.1 to 2.3.4 of Annex VI; ...
... (c) the
classification of the
intermediate as specified in section 4 of Annex VI; ...
ARTICLE-18: Registration of transported isolated intermediates [
go to this ARTICLE]
... (b) the
identity of the
intermediate as specified in sections 2.1 to 2.3.4 of Annex VI; ...
... (c) the
classification of the
intermediate as specified in section 4 of Annex VI; ...
ARTICLE-19: Joint submission of data on isolated intermediates by multiple registrants [
go to this ARTICLE]
ARTICLE-28: Duty to pre-register for phase-in substances [
go to this ARTICLE]
ARTICLE-49: Further information on on-site isolated intermediates [
go to this ARTICLE]
ARTICLE-68: Introducing new and amending current restrictions [
go to this ARTICLE]
... 1. When there is an unacceptable
risk to
human health or the
environment, arising from the
manufacture, use or placing on the
market of
substances, which needs to be addressed on a
Community-
wide basis, Annex XVII shall be amended in
accordance with the
procedure referred to in
Article 133(4) by adopting new
restrictions, or
amending current
restrictions in Annex XVII, for the
manufacture, use or placing on the
market of
substances on their own, in
preparations or in
articles, pursuant to the
procedure set out in
Articles 69 to
73. Any such
decision shall take into
account the
socio-economic impact of the
restriction,
including the
availability of alternatives. The first subparagraph shall not apply to the use of a
substance as an
on-site isolated intermediate. ...
ARTICLE-119: Electronic public access [
go to this ARTICLE]
... (i) as an intermediate; ...